Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Qiaojuan Guo, Mengwei Chen, Hanchuan Xu, Tianzhu Lu, Han Zhou, Yanyan Chen, Jingfeng Zong, Yun Xu, Bijuan Chen, Bingyi Wang, Lili Zhu, Jianji Pan & Shaojun Lin. (2020) Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience. Cancer Management and Research 12, pages 1387-1396.
Read now
Read now
Koh Miura, Hiroshi Shima, Naoko Takebe, Julie Rhie, Kennichi Satoh, Yoichiro Kakugawa, Masayuki Satoh, Makoto Kinouchi, Kuniharu Yamamoto, Yasuhiro Hasegawa, Masaaki Kawai, Kousuke Kanazawa, Tsuneaki Fujiya, Michiaki Unno & Ryuichi Katakura. (2017) Drug delivery of oral anti-cancer fluoropyrimidine agents. Expert Opinion on Drug Delivery 14:12, pages 1355-1366.
Read now
Read now
Masaaki Kawahara. (2014) Efficacy of S-1 in non-small cell lung cancer. Expert Opinion on Pharmacotherapy 15:13, pages 1927-1942.
Read now
Read now
Marcus S Noel & Aram F Hezel. (2013) New and emerging treatment options for biliary tract cancer. OncoTargets and Therapy 6, pages 1545-1552.
Read now
Read now
Articles from other publishers (16)
Xujia Li, Jinsheng Huang, Fenghua Wang, Qi Jiang, Lingli Huang, Shengping Li & Guifang Guo. (2023)
Efficacy and safety of SOXIRI
versus
mFOLFIRINOX in advanced pancreatic cancer
. Therapeutic Advances in Medical Oncology 15.
Crossref
Crossref
Xiaocheng Li, Zhiyang Jiang, Yongjuan Wu, Wei Gong, Xiaofeng Liao & Xiaogang Li. (2022) Case report: Conversion therapy for advanced intrahepatic cholangiocarcinoma using PD-1 inhibitor plus S-1 and nab-paclitaxel. Frontiers in Oncology 12.
Crossref
Crossref
Man-yi Zhu, Xue-song Sun, Shan-shan Guo, Qiu-yan Chen, Lin-quan Tang, Li-ting Liu & Hai-qiang Mai. (2021) Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?. Oral Oncology 122, pages 105539.
Crossref
Crossref
Thomas Groves, Christa Corley, Stephanie D. Byrum & Antiño R. Allen. (2021) The Effects of 5-Fluorouracil/Leucovorin Chemotherapy on Cognitive Function in Male Mice. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Xiao-Cui Hong, Qi-Lian Liang, Xing-Bo Luo, Ke-Hui Hu, Hai-Xia Yang, Wen-ting Ou & Hui-Jie Zhang. (2020) Clinical study of XiangShaLiuJunZi decoction combined with S-1 as maintenance therapy for stage III or IV gastric carcinoma and colorectal carcinoma. Medicine 99:19, pages e20081.
Crossref
Crossref
Elnaz Karimi, Behrooz Gharib, Nematollah Rostami, Latifeh Navidpour & Minoo Afshar. (2019) Clinical efficacy of a topical polyherbal formulation in the management of fluorouracil -associated hand-foot syndrome. Journal of Herbal Medicine 17-18, pages 100270.
Crossref
Crossref
Guoliang Qiao, Xiaoli Wang, Lei Zhou, Xinna Zhou, Yuguang Song, Shuo Wang, Lei Zhao, Michael A. Morse, Amy Hobeika, Jin Song, Xin Yi, Xuefeng Xia, Jun Ren & Herbert Kim Lyerly. (2019) Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clinical Cancer Research 25:5, pages 1494-1504.
Crossref
Crossref
H. Hayashi & T. Mitsudomi. (2017) S-1 as an option for second-line treatment of NSCLC. Is the ‘East Side Story’ applicable in the West?. Annals of Oncology 28:11, pages 2627-2629.
Crossref
Crossref
Jin Fengtong, Fu Jiangtao, Wang Yating, Wu Lili, Chen Jianbo & Wang Xiaofei. (2017) Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials. Open Medicine 12:1, pages 107-114.
Crossref
Crossref
Takashi Yamaguchi, Toshihito Seki, Ryosuke Inokuchi, Rinako Kawamura, Miki Murata, Koichi Matsuzaki, Osamu Nakashima, Tsutomu Kumabe & Kazuichi Okazaki. (2016) S-1 monotherapy in a patient with cholangiolocellular carcinoma: A case report. Molecular and Clinical Oncology.
Crossref
Crossref
Terumi Tanigawa, Maki Matoda, Akiko Yamamoto, Hidetaka Nomura, Sanshiro Okamoto, Kimihiko Sakamoto, Eiji Kondo, Kohei Omatsu, Kazuyoshi Kato & Nobuhiro Takeshima. (2015) Clinical usefulness of the oral chemotherapy agent S-1 in heavily pre-treated patients with advanced or recurrent cervical cancer. Archives of Gynecology and Obstetrics 293:3, pages 633-638.
Crossref
Crossref
Taiki Kajiwara, Koh Miura, Shinobu Ohnuma, Miki Shimada, Toshihiro Komura, Masahide Toshima, Atsushi Kohyama, Katsuyoshi Kudoh, Sho Haneda, Hiroaki Musha, Takeshi Naitoh, Tetsuhiko Shirasaka & Michiaki Unno. (2015) Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration. International Journal of Clinical Oncology 20:5, pages 913-921.
Crossref
Crossref
Toshihiro Komura, Koh Miura, Tetsuhiko Shirasaka, Shinobu Ohnuma, Miki Shimada, Taiki Kajiwara, Fumiyoshi Fujishima, Alex Philchenkov, Kei Nakagawa, Katsuyoshi Kudoh, Sho Haneda, Masahide Toshima, Atsushi Kohyama, Hiroaki Musha, Takeshi Naitoh, Chikashi Shibata & Michiaki Unno. (2014) Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects. International Journal of Clinical Oncology 20:1, pages 117-125.
Crossref
Crossref
M. Sanford. (2013) S-1 (Teysuno®): A Review of Its Use in Advanced Gastric Cancer in Non-Asian Populations. Drugs 73:8, pages 845-855.
Crossref
Crossref
Guido Deboever, Nick Hiltrop, Mike Cool & Guy Lambrecht. (2013) Alternative Treatment Options in Colorectal Cancer Patients With 5?Fluorouracil- or Capecitabine-Induced Cardiotoxicity. Clinical Colorectal Cancer 12:1, pages 8-14.
Crossref
Crossref
K. Miura, W. Fujibuchi & M. Unno. (2012) Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis 33:12, pages 2311-2319.
Crossref
Crossref